A simple and rapid method to characterize lipid fate in skeletal muscle

BMC Research Notes

Alexander V Chibalin²  Juleen R Zierath¹  Julie Massart² 

[1] Department of Physiology and Pharmacology, Section for Integrative Physiology, Karolinska Institutet, Stockholm, Sweden;Department of Molecular Medicine and Surgery, Section for Integrative Physiology, Karolinska Institutet, Stockholm, Sweden

关键词: Thin-layer chromatography;    Lipid metabolism;    Free fatty acids;    Skeletal muscle;   

Others  :  1132397
DOI  :  10.1186/1756-0500-7-391

 received in 2014-02-10, accepted in 2014-06-18,  发布年份 2014

【 摘 要 】

Background

Elevated fatty acids contribute to the development of type 2 diabetes and affect skeletal muscle insulin sensitivity. Since elevated intramuscular lipids and insulin resistance is strongly correlated, aberrant lipid storage or lipid intermediates may be involved in diabetes pathogenesis. The aim of this study was to develop a method to determine the dynamic metabolic fate of lipids in primary human skeletal muscle cells and in intact mouse skeletal muscle. We report a simple and fast method to characterize lipid profiles in skeletal muscle using thin layer chromatography.

Findings

The described method was specifically developed to assess lipid utilization in cultured and intact skeletal muscle. We determined the effect of a pan-diacylglycerol kinase (DGK) class I inhibitor (R59949) on lipid metabolism to validate the method. In human skeletal muscle cells, DGK inhibition impaired diacylglycerol (DAG) conversion to phosphatidic acid and increased triglyceride synthesis. In intact glycolytic mouse skeletal muscle, DGK inhibition triggered the accumulation of DAG species. Conversely, the DGK inhibitor did not affect DAG content in oxidative muscle.

Conclusion

This simple assay detects rapid changes in the lipid species composition of skeletal muscle with high sensitivity and specificity. Determination of lipid metabolism in skeletal muscle may further elucidate the mechanisms contributing to the pathogenesis of insulin resistance in type 2 diabetes or obesity.

【 授权许可】

   
2014 Massart et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Kelley DE, Goodpaster B, Wing RR, Simoneau J-A: Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol Endocrinol Metab 1999, 277:E1130-E1141.
• [2]Kim J-Y, Hickner RC, Cortright RL, Dohm GL, Houmard JA: Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 2000, 279:E1039-E1044.
• [3]Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH: Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997, 46:983-988.
• [4]Phillips DIW, Caddy S, Ilic V, Fielding BA, Frayn KN, Borthwick AC, Taylor R: Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 1996, 45:947-950.
• [5]Itani SI, Ruderman NB, Schmieder F, Boden G: Lipid-Induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 2002, 51:2005-2011.
• [6]Chibalin AV, Leng Y, Vieira E, Krook A, Bjornholm M, Long YC, Kotova O, Zhong Z, Sakane F, Steiler T, Nylen C, Wang J, Laakso M, Topham MK, Gilbert M, Wallberg-Henriksson H, Zierath JR: Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Cell 2008, 132:375-386.
• [7]Adams JM, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC, Mandarino LJ: Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004, 53:25-31.
• [8]Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Shulman GI: Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002, 277:50230-50236.
• [9]Al-Khalili L, Kramer D, Wretenberg P, Krook A: Human skeletal muscle cell differentiation is associated with changes in myogenic markers and enhanced insulin-mediated MAPK and PKB phosphorylation. Acta Physiol Scand 2004, 180:395-403.
• [10]Reis A, Rudnitskaya A, Blackburn GJ, Fauzi NM, Pitt AR, Spickett CM: A comparison of five lipid extraction solvent systems for lipidomic studies of human LDL. J Lipid Res 2013, 54:1812-1824.
• [11]Hara A, Radin NS: Lipid extraction of tissues with a low-toxicity solvent. Anal Biochem 1978, 90:420-426.
• [12]Kler RS, Sherratt HS, Turnbull DM: The measurement of mitochondrial beta-oxidation by release of 3H2O from [9,10-3H]hexadecanoate: application to skeletal muscle and the use of inhibitors as models of metabolic disease. Biochem Med Metab Biol 1992, 47:145-156.
• [13]Igal RA, Caviglia JM, de Gómez Dumm INT, Coleman RA: Diacylglycerol generated in CHO cell plasma membrane by phospholipase C is used for triacylglycerol synthesis. J Lipid Res 2001, 42:88-95.
• [14]Fuchs B, Süß R, Teuber K, Eibisch M, Schiller J: Lipid analysis by thin-layer chromatography—a review of the current state. J Chromatogr A 2011, 1218:2754-2774.
• [15]Peterson BL, Cummings BS: A review of chromatographic methods for the assessment of phospholipids in biological samples. Biomed Chromatogr 2006, 20:227-243.
• [16]Touchstone JC: Thin-layer chromatographic procedures for lipid separation. J Chromatogr B Biomed Sci Appl 1995, 671:169-195.
• [17]White T, Bursten S, Federighi D, Lewis RA, Nudelman E: High-resolution separation and quantification of neutral lipid and phospholipid species in mammalian cells and sera by multi-one-dimensional thin-layer chromatography. Anal Biochem 1998, 258:109-117.